Activation-induced cell death in human peripheral blood lymphocytes after stimulation with silicate in vitro

Int J Oncol. 1998 Jun;12(6):1355-9. doi: 10.3892/ijo.12.6.1355.

Abstract

Silica and related substances such as silicate have been proven to possess "adjuvant effects". We have previously reported a finding of polyclonal human T cell activation induced by silicate as a superantigen in vitro. In this study, we observed activation-induced cell death in human lymphocytes after stimulation with chrysotile, a kind of silicate. Apoptotic cells were detected flow cytometrically using the TUNEL assay, and the maximum appearance of TUNEL positive cells occurred on day 4 of incubation. Simultaneously the manifestation of small-sized cells in the specimens increased implying apoptosis. Fas expression on lymphocytes increased to day 3 of incubation with chrysotile, and then spontaneously decreased on day 4 when remarkable apoptosis could be detected. Based on these results it is conceivable that activation-induced cell death occurred through Fas-Fas ligand interaction in lymphocytes after stimulation with silicate in a concentration with which no acute cytotoxicity has been detected. Whether and how the repeated apoptosis in definite clones of lymphocytes causes the induction of sFas synthesis need clarification.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asbestos, Serpentine / pharmacology
  • CD3 Complex / biosynthesis
  • CD3 Complex / drug effects
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / physiology
  • CD8-Positive T-Lymphocytes / drug effects
  • CD8-Positive T-Lymphocytes / physiology
  • Carcinogens / administration & dosage
  • Carcinogens / pharmacology
  • Cell Death / drug effects
  • Fas Ligand Protein
  • Humans
  • Lipopolysaccharide Receptors / biosynthesis
  • Lipopolysaccharide Receptors / drug effects
  • Lymphocyte Activation / drug effects
  • Membrane Glycoproteins / biosynthesis
  • Membrane Glycoproteins / drug effects
  • Silicates / administration & dosage
  • Silicates / immunology
  • Silicates / pharmacology*
  • Superantigens / pharmacology
  • T-Lymphocytes / cytology
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / physiology

Substances

  • Asbestos, Serpentine
  • CD3 Complex
  • Carcinogens
  • FASLG protein, human
  • Fas Ligand Protein
  • Lipopolysaccharide Receptors
  • Membrane Glycoproteins
  • Silicates
  • Superantigens